Cargando…
Prophylactic treatment of rapamycin ameliorates naturally developing and episode -induced heterotopic ossification in mice expressing human mutant ACVR1
BACKGROUND: Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal-dominant disease characterized by heterotopic ossification (HO) in soft tissues and caused by a mutation of the ACVR1A/ALK2 gene. Activin-A is a key molecule for initiating the process of HO via the activation of mTOR, while...
Autores principales: | Maekawa, Hirotsugu, Kawai, Shunsuke, Nishio, Megumi, Nagata, Sanae, Jin, Yonghui, Yoshitomi, Hiroyuki, Matsuda, Shuichi, Toguchida, Junya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245788/ https://www.ncbi.nlm.nih.gov/pubmed/32448372 http://dx.doi.org/10.1186/s13023-020-01406-8 |
Ejemplares similares
-
Recapitulation of pro-inflammatory signature of monocytes with ACVR1A mutation using FOP patient-derived iPSCs
por: Maekawa, Hirotsugu, et al.
Publicado: (2022) -
Collagen X Is Dispensable for Hypertrophic Differentiation and Endochondral Ossification of Human iPSC‐Derived Chondrocytes
por: Kamakura, Takeshi, et al.
Publicado: (2023) -
An mTOR Signaling Modulator Suppressed Heterotopic Ossification of Fibrodysplasia Ossificans Progressiva
por: Hino, Kyosuke, et al.
Publicado: (2018) -
Myelin protein zero (P0)- and Wnt1-Cre marked muscle resident neural crest-derived mesenchymal progenitor cells give rise to heterotopic ossification in mouse models
por: Zhao, Chengzhu, et al.
Publicado: (2022) -
Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1
por: Aykul, Senem, et al.
Publicado: (2022)